Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NextPharma Upgrades SVA Facility In Belgium
The newly established SVA for both solution and lyophilized vials, which is anticipated to be begin operations by the end of 2010, will add to the current sterile
The newly established SVA for both solution and lyophilized vials, which is anticipated to be begin operations by the end of 2010, will add to the current sterile
The 3T3-L1 system, which was originally derived from Swiss mouse embryo tissue by Dr Howard Green of the department of cell biology at Harvard Medical School, has been
According to the agreement, Omeros is responsible for clinical and commercial milestone payments to Asubio. Omeros would also pay a single-digit royalty to Asubio upon potential sale of
In the executive board Mr Oleas will be responsible for GEA Farm Technologies and GEA Heat Exchangers segments. He has been a member of the company’s executive board
Maybridge claimed that the Ro3 500 Fragment Library, selected from the original Maybridge “Rule-of-Three” (Ro3) compliant set, is designed to be a convenient, cost-effective entry point to fragment
GlycosBio has created a platform that can consume carbon from multiple non-sugar feedstock sources to produce a variety of chemical products. The approach not only eliminates the risk
Headquartered in Norcross, GA, Spear has been instrumental in helping the client develop and implement comprehensive project controls programs including methods, procedures, processes and systems. Currently, Spear is
Affymax said that the milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan. Hematide
The proprietary, patented technology platform of Biocrates is based on mass spectrometry. Chenomx analyzes biological samples utilizing a patented methodology based on Nuclear Magnetic Resonance (NMR) spectroscopy. Mass
The license comprises the patent application entitled ‘Identification of Ergothioneine Transporter and Therapeutic Uses Thereof.’ This transporter is present in human cells, especially red and white blood cells,